{
    "medicine_id": "be32a78692c09e3b92fb6050c1bfeefd00627647",
    "platform_id": "DB04944",
    "metadata": {
        "name": "Fulyzaq 125 mg 1 Tablet coated",
        "composition": "125 mg 1 Acadesine",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in cardiac reperfusion injury cardiovascular disorders and coronary artery disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Acadesine has been shown to induce cell death apoptosis selectively in B cells taken from healthy subjects and patients with B CLL with little effect on T cells As T cells have an important role in fighting infection it is anticipated that patients treated with acadesine will have a reduced risk of serious infections compared to those on current chemotherapies",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}